This Article Full Text Full Text (PDF) All Versions of this Article: 108/21/2631    most recent 01.CIR.0000101927.70100.41v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gamboa, A. Articles by Biaggioni, I. Search for Related Content PubMed PubMed Citation Articles by Gamboa, A. Articles by Biaggioni, I. Related Collections Cardiovascular Pharmacology Other Vascular biology

(Circulation. 2003;108:2631.)
© 2003 American Heart Association, Inc.

Clinical Investigation and Reports

Blockade of Nucleoside Transport Is Required for Delivery of Intraarterial Adenosine Into the Interstitium

Relevance to Therapeutic Preconditioning in Humans

Alfredo Gamboa, MD; Andrew C. Ertl, PhD; Fernando Costa, MD; Ginnie Farley; M. Lisa Manier; David L. Hachey, PhD; André Diedrich, MD; Italo Biaggioni, MD

From the Department of Medicine, Vanderbilt University, Nashville, Tenn.

Correspondence to Italo Biaggioni, MD, 1500 21st Ave S, Suite 3500, Vanderbilt University, Nashville, TN 37212. E-mail italo.biaggioni{at}vanderbilt.edu

Received June 11, 2003; revision received August 7, 2003; accepted August 8, 2003.

Background— Adenosine, a known mediator of preconditioning, has been infused into the coronary circulation to induce therapeutic preconditioning, eg, in preparation for angioplasty. However, results have been disappointing. We tested the hypothesis that endothelial nucleoside transporter acts as a barrier impeding the delivery of intravascular adenosine into the underlying myocardium and that this can be overcome with dipyridamole, a nucleoside transporter blocker.

Methods and Results— We infused saline or adenosine (0.125 and 0.5 mg/min) into the brachial artery while monitoring forearm blood flow (FBF) and interstitial adenosine levels with microdialysis probes implanted in the flexor digitorum superficialis of the forearm in 7 healthy volunteers during intravenous administration of saline or dipyridamole (loading dose, 0.142 mg/kg per min for 5 minutes followed by 0.004 mg/kg per min). Adenosine produced near maximal forearm vasodilation, increasing FBF from 4.0±0.7 to 10.4±1.9 and 13.1±1.6 mL/100 mL per min for the low and high doses, respectively, but did not increase muscle dialysate adenosine concentration (from 88±21 to 65±23 and 85±26 nmol/L). Intravenous dipyridamole enhanced resting muscle dialysate adenosine (from 77±25 to 147±50 nmol/L), adenosine-induced increase in FBF (from 4.1±0.8 to 12.6±3 and 15.1±3 mL/100 mL per min for the low and high dose, respectively), and the delivery of adenosine into the interstitium (to 290±80 and 299±143 nmol/L for the low and high dose, respectively, P=0.04).

Conclusions— Intravascular adenosine is likely ineffective in inducing myocardial preconditioning because of poor interstitial delivery. This can be overcome by blocking the nucleoside transporter with dipyridamole.

Key Words: adenosine • ischemia • endothelium • blood flow

This article has been cited by other articles:

				M. Bosselaar, H. Boon, L. J. C. van Loon, P. H. H. van den Broek, P. Smits, and C. J. Tack Intra-arterial AICA-riboside administration induces NO-dependent vasodilation in vivo in human skeletal muscle Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E759 - E766. [Abstract] [Full Text] [PDF]

				C. Shibao, A. Gamboa, A. Diedrich, C. Dossett, L. Choi, G. Farley, and I. Biaggioni Acarbose, an {alpha}-Glucosidase Inhibitor, Attenuates Postprandial Hypotension in Autonomic Failure Hypertension, July 1, 2007; 50(1): 54 - 61. [Abstract] [Full Text] [PDF]

				E. A. Martin, W. T. Nicholson, T. B. Curry, J. H. Eisenach, N. Charkoudian, and M. J. Joyner Adenosine transporter antagonism in humans augments vasodilator responsiveness to adenosine, but not exercise, in both adenosine responders and non-responders J. Physiol., February 15, 2007; 579(1): 237 - 245. [Abstract] [Full Text] [PDF]

				O. Frobert, G. Haink, U. Simonsen, C. H. Gravholt, M. Levin, and A. Deussen Adenosine concentration in the porcine coronary artery wall and A2A receptor involvement in hypoxia-induced vasodilatation J. Physiol., January 15, 2006; 570(2): 375 - 384. [Abstract] [Full Text] [PDF]

				A. Gamboa, R. Abraham, A. Diedrich, C. Shibao, S. Y. Paranjape, G. Farley, and I. Biaggioni Role of Adenosine and Nitric Oxide on the Mechanisms of Action of Dipyridamole Stroke, October 1, 2005; 36(10): 2170 - 2175. [Abstract] [Full Text] [PDF]

				N. P. Riksen, E. E. M. van Ginneken, P. H. H. van den Broek, P. Smits, and G. A. Rongen In vivo evidence against a role for adenosine in the exercise pressor reflex in humans J Appl Physiol, August 1, 2005; 99(2): 522 - 527. [Abstract] [Full Text] [PDF]

				G. Jacob, A. Gamboa, A. Diedrich, C. Shibao, D. Robertson, and I. Biaggioni Tyramine-Induced Vasodilation Mediated by Dopamine Contamination: A Paradox Resolved Hypertension, August 1, 2005; 46(2): 355 - 359. [Abstract] [Full Text] [PDF]

				H. Lu, C. Chen, and C. Klaassen TISSUE DISTRIBUTION OF CONCENTRATIVE AND EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS IN MALE AND FEMALE RATS AND MICE Drug Metab. Dispos., December 1, 2004; 32(12): 1455 - 1461. [Abstract] [Full Text] [PDF]